Abstract:BACKGROUND:Portal vein thrombosis (PVT) used to be a contraindication for liver transplantation (LT). This obstacle has been delt with following the improvement of LT-related techniques and therapeutic approaches to thrombosis. But the effect of PVT on LT outcomes is still controversial. We reviewed retrospectively the outcome of LT patients with PVT as well as risk factors and surgical management according to PVT grades. METHODS:A total of 465 adult LTs were performed from December 2002 through December 2006. Operative findings and the result of preoperative ultrasonography and imaging were reviewed for PVT grading (Yerdel grading). Comparison of risk factors, variables associated with perioperative period and prognosis between recipients with and without PVT is based on the grades. RESULTS:In the 465 LTs, 42 were operatively confirmed to have PVT (9.0%) (19 recipients with grade 1, 14 with grade 2, 7 with grade 3, and 2 with grade 4). Increased age and treatment of portal hypertension were associated with PVT. Grade 1 or 2 PVT was treated by direct anastomosis or single thrombectomy. In grade 3 PVT patients, the donor PV was directly anastomosed to the dilated branch of the recipient portal venous system or to the distal open superior mesenteric vein through an interposition vein graft if needed. Grade 4 PVT was managed by our modified cavoportal hemitransposition technique. The comparison between PVT patients and controls showed no significant difference in operative duration and blood transfusion (P>0.05). The flow rate of the PV was lower in the PVT patients (48.881+/-12.788 cm/s) than in the controls (57.172+/-21.715 cm/s, P<0.05). The PVT patients had such postoperative complications as renal failure and PV rethrombosis (P<0.05). The 1-year survival rates in PVT and non-PVT patients were 78.6% and 76.4% respectively (P>0.05); the 3-year survival rates were 58.8% and 56.4% respectively (P>0.05). CONCLUSIONS:PVT is not contraindicated for LT if it is graded. PVT recipients may have post-transplantation complications like renal failure and PV rethrombosis, and operative difficulty and patient survival are similar to those in recipients without PVT. Development of therapeutic approaches and accumulation of experience in dealing with PVT further improve the outcomes of LT in PVT recipients.

Long-term results of vascular stent placements for portal vein stenosis following liver transplantation

Liver Transplant Recipients with Portal Vein Thrombosis:A Single Center Retrospective Study

Treatment Options for Portal Hypertension in the Era of Liver Transplantation

Portal vein stent placement after hepatobiliary and pancreatic surgery

Interventional Management of Portal Vein Stenosis after Liver Transplant: Single Center Experience.

[Liver Transplantation for the Patients with End Stage Liver Disease and Portal Vein Thrombosis].

Analysis of three-dimensional visualization of severe portal vein stenosis after liver transplantation and clinical efficacy of portal vein stent implantation

[Percutaneous transhepatic metallic stent placement for the treatment of post-transplantation portal vein stenosis]

Endovascular interventional therapy of portal vein stenosis after pediatric liver transplantation

Endovascular treatment of portal vein stenosis after pediatric liver transplantation for biliary atresia

Portal Vein Stenting Combined 125I Particle Implanted Followed by Transarterial Chemoembolization in the Treatment of Hepatocellular Carcinoma with Portal Vein Tumor Thrombus

Liver transplantation in adults with portal vein thrombosis: Data from the China Liver Transplant Registry.

Treatment of Hepatic Venous Outflow Stenosis after Living Donor Liver Transplantation by Insertion of an Expandable Metallic Stent.

Exploration of interventional therapy strategy for portal vein occlusion: a case series study

Long-term patency and clinical outcome of the transjugular intrahepatic portosystemic shunt using the expanded polytetrafluoroethylene stent-graft

Management Experience of Portal Vein Thrombosis of Liver Transplantation

Role of transjugular intrahepatic portosystemic shunt in the control of variceal bleeding and ascites due to portal hypertension

[Clinical study of transjugular intrahepatic portosystemic shunt with Viatorr stent in 43 cases]

Shunting Branch of Portal Vein and Stent Position Predict Survival after Transjugular Intrahepatic Portosystemic Shunt

Treatments and outcomes of intra-operative portal vein thrombosis in living-donor liver transplantation due to biliary atresia

Comparison of Transjugular Intrahepatic Portosystemic Shunt in the Treatment of Cirrhosis With or Without Portal Vein Thrombosis: A Retrospective Study